258 related articles for article (PubMed ID: 12463096)
1. [Autoantibodies: new upstream targets of paroxysmal atrial fibrillation in patients with congestive heart failure].
Baba A; Yoshikawa T; Chino M; Murayama A; Mitani K; Nakagawa S; Fujii I; Shimada M; Koyama T; Akaishi M; Mitamura H; Ogawa S;
J Cardiol; 2002 Nov; 40(5):217-23. PubMed ID: 12463096
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibodies against sarcolemmal Na-K-ATPase in patients with dilated cardiomyopathy: autoimmune basis for ventricular arrhythmias in patients with congestive heart failure].
Baba A; Yoshikawa T; Mitamura H; Akaishi M; Ogawa S
J Cardiol; 2002 Jan; 39(1):50-1. PubMed ID: 11828798
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions.
Levy S
Anadolu Kardiyol Derg; 2002 Mar; 2(1):55-60. PubMed ID: 12101796
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy.
Baba A; Yoshikawa T; Fukuda Y; Sugiyama T; Shimada M; Akaishi M; Tsuchimoto K; Ogawa S; Fu M
Eur Heart J; 2004 Jul; 25(13):1108-15. PubMed ID: 15231368
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal dyspnea and atrial fibrillation predict Cheyne-Stokes respirations in patients with congestive heart failure.
Blackshear JL; Kaplan J; Thompson RC; Safford RE; Atkinson EJ
Arch Intern Med; 1995 Jun; 155(12):1297-302. PubMed ID: 7778961
[TBL] [Abstract][Full Text] [Related]
6. Late incidence and predictors of persistent or recurrent heart failure in patients with mitral prosthetic valves.
Ruel M; Rubens FD; Masters RG; Pipe AL; Bédard P; Mesana TG
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):278-83. PubMed ID: 15282466
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors of atrial fibrillation in preterminal inpatients aged 60 years and over.
Yang JF; Liu B; Liu DG; Luo Y; Fang F
Chin Med J (Engl); 2008 Oct; 121(20):2046-9. PubMed ID: 19080273
[TBL] [Abstract][Full Text] [Related]
8. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication.
Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP
Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251
[TBL] [Abstract][Full Text] [Related]
9. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction.
Pedersen OD; Bagger H; Køber L; Torp-Pedersen C;
Int J Cardiol; 2005 Apr; 100(1):65-71. PubMed ID: 15820287
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against the myocardial beta1-adrenergic and M2-muscarinic receptors in patients with congestive heart failure.
Zhang L; Hu D; Li J; Wu Y; Liu X; Yang X
Chin Med J (Engl); 2002 Aug; 115(8):1127-31. PubMed ID: 12215275
[TBL] [Abstract][Full Text] [Related]
11. A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure.
Nikolaev VO; Boivin V; Störk S; Angermann CE; Ertl G; Lohse MJ; Jahns R
J Am Coll Cardiol; 2007 Jul; 50(5):423-31. PubMed ID: 17662395
[TBL] [Abstract][Full Text] [Related]
12. [Impact of atrial fibrillation on prognosis of chronic heart failure patients with left ventricular ejection fraction>or=0.5].
Zhan H; Tse HF; Cao JM; Lau CP
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):200-3. PubMed ID: 18419950
[TBL] [Abstract][Full Text] [Related]
13. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
[TBL] [Abstract][Full Text] [Related]
14. [Frequency and predictors of atrial fibrillation in severe mitral regurgitation].
Duran NE; Duran I; Sönmez K; Gençbay M; Akçay A; Turan F
Anadolu Kardiyol Derg; 2003 Jun; 3(2):129-34. PubMed ID: 12826507
[TBL] [Abstract][Full Text] [Related]
15. Predictors of paroxysmal atrial fibrillation in patients undergoing aortic valve replacement.
Banach M; Goch A; Misztal M; Rysz J; Jaszewski R; Goch JH
J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1569-76. PubMed ID: 18023685
[TBL] [Abstract][Full Text] [Related]
16. [Variation in the plasma concentration of B-type natriuretic peptide in emergent paroxysmal atrial fibrillation, in acute pulmonary embolism, in acute coronary syndrome and in dilated cardiomyopathy].
Coppola A; De Paola G; Suppa M; Maggi B; Giancaspro G; Colzi M; Arcieri A; Scarpellini G; Manetti E; Lacenere L; Gerratana G; Santulli M; Aguglia F
Ann Ital Med Int; 2005; 20(3):167-86. PubMed ID: 16250184
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy.
Baba A; Yoshikawa T; Ogawa S
J Am Coll Cardiol; 2002 Sep; 40(6):1153-9. PubMed ID: 12354443
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.
De Bonis M; Lapenna E; Verzini A; La Canna G; Grimaldi A; Torracca L; Maisano F; Alfieri O
Ann Thorac Surg; 2008 Mar; 85(3):932-9. PubMed ID: 18291174
[TBL] [Abstract][Full Text] [Related]
20. Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
Rienstra M; Smit MD; Nieuwland W; Tan ES; Wiesfeld AC; Anthonio RL; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC
Am Heart J; 2007 Jan; 153(1):120-6. PubMed ID: 17174649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
